|
시장보고서
상품코드
2026354
주입 요법 시장 규모, 점유율 및 성장 분석 : 제품별, 적응증별, 요법별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Infusion Therapy Market Size, Share, and Growth Analysis, By Product (Infusion Pumps, Infusion Set), By Indication (Cancer, Gastrointestinal Diseases/Disorders), By Therapy, By Application, By End-user, By Region - Industry Forecast 2026-2033 |
||||||
세계의 주입 요법 시장 규모는 2024년에 474억 3,000만 달러로 평가되었고, 2025년 506억 1,000만 달러에서 2033년까지 850억 2,000만 달러로 확대되어 예측 기간(2026-2033년)에 CAGR 6.7%로 성장할 전망입니다.
세계 주입 요법 시장은 고령화와 만성질환 유병률 증가에 힘입어 괄목할 만한 성장세를 보이고 있습니다. 약물을 혈류로 직접 주입하는 주입 요법의 효율성은 치료 결과를 향상시키는 동시에 환자 개개인의 필요에 따라 정확한 투여를 가능하게 합니다. 항생제 및 화학요법에서 영양지원에 이르기까지 그 용도는 매우 다양하며, 다양한 질환에 대한 유연한 치료 옵션을 제공합니다. 재택치료에 대한 수요 증가와 수액 기술의 발전도 시장 확대를 더욱 촉진하고 있습니다. 그러나 감염 위험, 카테터 사용에 따른 합병증 및 관련 비용 등의 문제를 해결해야 합니다. 전반적으로, 환자의 치료 선호도가 변화하는 가운데 효과적인 의료 솔루션에 대한 지속적인 수요에 힘입어 시장은 계속 성장할 것으로 예측됩니다.
세계 주입 요법 시장의 성장 요인
암, 당뇨병, 심혈관 질환 등 만성질환의 발병률 증가는 수액요법 제품 및 서비스에 대한 수요를 크게 견인하고 있습니다. 이러한 건강 문제가 더욱 광범위하게 확산됨에 따라 주입 요법과 같은 효과적인 치료법의 필요성이 증가하고 있습니다. 이러한 수요의 급증은 혁신적인 수액 주입 방법이 약물과 영양분을 환자에게 직접 전달하는 데 중요한 역할을 하는 복잡한 질병 관리의 광범위한 추세를 반영합니다. 그 결과, 의료 서비스 제공업체들은 환자의 치료 결과를 개선하기 위해 점적 요법을 점점 더 많이 채택하고 있으며, 만성 질환 관리를 위한 첨단 솔루션을 찾는 움직임이 세계 점적 요법 시장의 성장을 가속하고 있습니다.
세계 주입 요법 시장 성장 억제요인
세계 수액요법 시장이 직면한 가장 큰 도전은 수액요법 제품 및 서비스와 관련된 높은 비용입니다. 이러한 경제적 장벽은 의료에 대한 접근이 종종 제한되는 개발도상국에서 특히 두드러집니다. 그 결과, 높은 비용으로 인해 첨단 주입 요법의 도입과 이용이 제한되어 시장 성장을 저해할 수 있습니다. 이들 지역의 의료 인프라와 경제적 자원의 격차는 이 문제를 더욱 심화시켜 광범위한 인구층이 필요한 치료를 받지 못하는 상황을 초래하고 있습니다. 전 세계적으로 수액 치료의 가용성과 효과를 높이기 위해서는 이러한 비용 관련 장벽을 해결하는 것이 필수적입니다.
세계 수액요법 시장 동향
세계 수액요법 시장에서는 재택의료 솔루션에 대한 선호도가 높아짐에 따라 재택 수액요법으로의 큰 전환이 일어나고 있습니다. 환자들은 전통적인 임상 환경이 아닌 익숙한 환경에서 정맥 내 치료를 받음으로써 편리함, 편안함, 비용 효율성을 점점 더 많이 원하고 있습니다. 이러한 추세는 보다 안전하고 효율적인 재택 치료를 가능하게 하는 기술의 발전에 힘입어 더욱 가속화되고 있습니다. 의료 제공업체와 보험사도 이러한 이점을 인식하고 있으며, 이는 투자 증가와 혁신적인 휴대용 수액 장치 개발로 이어지고 있습니다. 그 결과, 재택 수액 서비스에 대한 수요는 환자의 치료 순응도와 전반적인 건강 결과를 개선하는 데 기여할 것으로 예측됩니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 주입 요법 시장 규모 : 제품별
세계의 주입 요법 시장 규모 : 적응증별
세계의 주입 요법 시장 규모 : 세라피별
세계의 주입 요법 시장 규모 : 용도별
세계의 주입 요법 시장 규모 : 최종사용자별
세계의 주입 요법 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.05.26Global Infusion Therapy Market size was valued at USD 47.43 Billion in 2024 and is poised to grow from USD 50.61 Billion in 2025 to USD 85.02 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).
The global infusion therapy market is experiencing notable growth, propelled by an aging population and the rising incidence of chronic diseases. Infusion therapy's efficiency in delivering medications directly into the bloodstream enhances treatment outcomes while allowing for precise dosing tailored to individual patient needs. With a diverse range of applications-from antibiotics and chemotherapy to nutritional support-it offers flexibility in treatment options across various medical conditions. The demand for home healthcare and advancements in infusion technology further fuel market expansion. However, challenges such as infection risks, complications from catheter use, and associated costs need to be addressed. Overall, the market is poised for continued growth, driven by the ongoing need for effective healthcare solutions amidst evolving patient care preferences.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infusion Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Infusion Therapy Market Segments Analysis
Global Infusion Therapy Market is segmented by Product, Indication, Therapy, Application, End-user and region. Based on Product, the market is segmented into Infusion Pumps, Infusion Set and Accessories. Based on Indication, the market is segmented into Cancer, Gastrointestinal Diseases/Disorders, Congestive Heart Failure, Rheumatoid Arthritis, Hemophilia, Immune Deficiencies and Others. Based on Therapy, the market is segmented into Antibiotic/Antiviral, Anti-coagulation, Anti-emetics, Blood Component Stimulating Factor, Chemotherapy, Nutrition, Hydration and Pain Management. Based on Application, the market is segmented into Chemotherapy, Diabetes, Gastrointestinal Diseases, Pain management and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Homecare Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Infusion Therapy Market
The rising incidence of chronic conditions, including cancer, diabetes, and cardiovascular diseases, is significantly driving the demand for infusion therapy products and services. As these health issues become more widespread, the need for effective treatment options like infusion therapy has intensified. This surge in demand reflects a broader trend towards managing complex medical conditions, where innovative infusion methods play a crucial role in delivering medications and nutrients directly to patients. Consequently, healthcare providers are increasingly adopting infusion therapy to enhance patient outcomes, thereby fueling growth in the global infusion therapy market as they seek advanced solutions for chronic disease management.
Restraints in the Global Infusion Therapy Market
A significant challenge facing the global infusion therapy market is the elevated costs linked to infusion therapy products and services. This financial barrier is particularly pronounced in developing nations, where healthcare access is often constrained. Consequently, the high expenses can limit the adoption and utilization of advanced infusion therapies, hindering market growth. The disparity in healthcare infrastructure and economic resources in these regions further exacerbates the issue, preventing a broad segment of the population from accessing necessary treatments. Addressing these cost-related obstacles will be crucial for enhancing the availability and effectiveness of infusion therapies worldwide.
Market Trends of the Global Infusion Therapy Market
The Global Infusion Therapy market is experiencing a significant shift towards home infusion therapy, driven by a rising preference for home-based healthcare solutions. Patients increasingly seek the convenience, comfort, and cost-effectiveness of receiving intravenous treatments in familiar surroundings rather than traditional clinical environments. This trend is further propelled by advancements in technology, enabling safer and more efficient home administration of therapies. Healthcare providers and payers are also recognizing the benefits, leading to increased investments and the development of innovative portable infusion devices. As a result, the demand for home infusion services is expected to enhance patient adherence and overall health outcomes.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2025
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
Global Infusion Therapy Market Size by Product & CAGR (2026-2033)
- Market Overview
- Infusion Pumps
- Ambulatory Infusion Pumps
- Stationary Infusion Pumps
- Syringe Infusion Pumps
- Disposable Pumps
- Large Volume Pumps
- Elastomeric pumps
- Infusion Set
- Accessories
Global Infusion Therapy Market Size by Indication & CAGR (2026-2033)
- Market Overview
- Cancer
- Gastrointestinal Diseases/Disorders
- Congestive Heart Failure
- Rheumatoid Arthritis
- Hemophilia
- Immune Deficiencies
- Others
Global Infusion Therapy Market Size by Therapy & CAGR (2026-2033)
- Market Overview
- Antibiotic/Antiviral
- Anti-coagulation
- Anti-emetics
- Blood Component Stimulating Factor
- Chemotherapy
- Nutrition
- Hydration
- Pain Management
Global Infusion Therapy Market Size by Application & CAGR (2026-2033)
- Market Overview
- Chemotherapy
- Diabetes
- Gastrointestinal Diseases
- Pain management
- Others
Global Infusion Therapy Market Size by End-user & CAGR (2026-2033)
- Market Overview
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Homecare Settings
Global Infusion Therapy Market Size & CAGR (2026-2033)
- North America (Product, Indication, Therapy, Application, End-user)
- US
- Canada
- Europe (Product, Indication, Therapy, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product, Indication, Therapy, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product, Indication, Therapy, Application, End-user)
- Brazil
- Rest of Latin America
- Middle East & Africa (Product, Indication, Therapy, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Option Care Health Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ICU Medical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Moog Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fresenius SE & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Smiths Medical (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- JMS Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Caesarea Medical Electronics (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CareFusion Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Poly Medicure Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- 3M Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teleflex Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Edwards Lifesciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Coloplast A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Convatec Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
